Compare Heron Therapeutics Inc (HRTX) vs Energy Select Sector SPDR Fund (XLE) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Heron Therapeutics Inc vs Energy Select Sector SPDR Fund — how do they compare? Heron Therapeutics Inc trades at $0.37 (market cap $68.01M), while Energy Select Sector SPDR Fund trades at $64.88 (market cap $40.84B). The key difference: Energy Select Sector SPDR Fund is far larger — about 600.5× Heron Therapeutics Inc's market cap, and Energy Select Sector SPDR Fund is trading nearer its 52-week high, Heron Therapeutics Inc nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Heron Therapeutics Inc for 35 Days and Energy Select Sector SPDR Fund for 67 Days on average.
| HRTX | XLE | |
|---|---|---|
Market Cap | $68.01M | $40.84B |
Volume | 1,891,941 | 50,409,268 |
Sector | Health | — |
52-Week High | $1.49 | $65.93 |
52-Week Low | $0.27 | $42.61 |
Typical Hold Time | 35 Days | 67 Days |
Enterprise Value | $174.75M | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Heron Therapeutics (HRTX) is trading at $0.39, up 17.58% today, with a bullish technical outlook from moving averages but mixed signals from oscillators. The company maintains strong gross margins of 70.07% but continues to report net losses, with Q2 2026 missing both EPS and revenue expectations. Analyst sentiment remains overwhelmingly positive with 89% buy ratings despite recent earnings disappointments and negative profitability metrics.
While analyst consensus is strongly bullish, HRTX faces significant fundamental challenges including consistent net losses, negative ROE of -78.72%, and cash flow concerns. The stock's current momentum appears driven by technical factors rather than improving fundamentals, creating a high-risk investment profile that requires careful monitoring of upcoming Q3 earnings and revenue stabilization efforts.
XLE trades at $63.38, down 0.58% with a bullish technical signal from moving averages. The ETF faces mixed sentiment amid oil price volatility, with recent news highlighting Middle East tensions and strategic reserve releases. Key support sits at $62-63 while resistance levels cluster around $64-65. The fund's 91% oil and gas concentration makes it highly sensitive to crude price movements.
Outlook remains tied to oil market dynamics with geopolitical risks and Fed policy as key drivers. The bullish technical setup suggests near-term upside potential, though energy sector volatility requires careful risk management given the concentrated exposure to commodity prices.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Heron Therapeutics Inc
Heron Therapeutics is a commercial-stage biotechnology company focused on improving patient care. It develops best-in-class medicines for pain management and cancer care to address unmet medical needs.
Read more on HRTX →About Energy Select Sector SPDR Fund
In seeking to track the performance of the index, the fund employs a replication strategy. It generally invests substantially all, but at least 95%, of its total assets in the securities comprising the index. The index includes companies that have been identified as energy companies by the GICS®, including securities of companies from the following industries: oil, gas and consumable fuels; and energy equipment and services. It is non-diversified.
Read more on XLE →
